Some new docs on Sedar, This a read, Galbraiths statement about the new PDUFA
“While we are disappointed by the extension of the review period by FDA, we look forward to continuing discussions with the FDA during the review process,” said Kenneth Galbraith, Chief Executive Officer of Liminal BioSciences. “We remain committed to bringing this much needed treatment forward to help patients with this serious disease.”
Also, fun fact Thomvest is located at 65 Queen St W, Toronto ...... which is in "The Thomson Building".